Try our Advanced Search for more refined results
Astellas Pharma Inc.
-
Discovery | Filed: April 25, 2024 | Entered: April 25, 2024 Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals Inc.'s Sur-Reply Claim Construction Brief filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth)
-
Appeal | Filed: April 25, 2024 | Entered: April 25, 2024 Astellas Pharma Inc. et al v. Lupin Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
USCA Notice of Appeal and Docket Transmitted
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 211 Notice of Appeal (Federal Circuit). (oam)
-
Appeal | Filed: April 25, 2024 | Entered: April 25, 2024 Astellas Pharma Inc. et al v. Lupin Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
USCA Appeal Record Sent to Reporter Warner
Notification regarding 211 Notice of Appeal (Federal Circuit), sent to Reporter Warner (oam)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login